Home/Filings/4/0001209191-14-009688
4//SEC Filing

IDENIX PHARMACEUTICALS INC 4

Accession 0001209191-14-009688

CIK 0001093649operating

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:20 PM ET

Size

5.5 KB

Accession

0001209191-14-009688

Insider Transaction Report

Form 4
Period: 2014-02-10
Mayers Douglas L
EVP and Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2014-02-10+100,000100,000 total
    Exercise: $7.01Exp: 2024-02-09Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]This option vests in 48 equal monthly installments beginning on February 28, 2014 and continuing thereafter on the last day of each of the next succeeding 47 months.

Issuer

IDENIX PHARMACEUTICALS INC

CIK 0001093649

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001093649

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:20 PM ET
Size
5.5 KB